PTHL
NASDAQPheton Holdings Ltd
Pheton Holdings Ltd (PTHL) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. There were no new wire items for PTHL in the last 30 days. The most recent was published Jan 13, 2026.
Latest news
24 items- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- PRPheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol ChangeBEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, announced today that it will change its corporate name to iTonic Holdings Ltd, and change its stock ticker symbol to "ITOC" (collectively, the "Corporate Events"). The Company anticipates that the Corporate Events will be effective upon the commencement of trading on the Nasdaq Capital Market on January 16, 2026 (U.S. Eastern Time), at which time the Company's Class A ordinary shares will cease trading under the current ticker symbol "PTHL" and will begin tradi
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- PRPheton Holdings Ltd Announces Closing of Share Acquisition with iTonic CorporationBeijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ:PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the successful completion of its acquisition of 51% of the total outstanding shares of iTonic Corporation (the "Target"), a U.S.-based integrated home health AI company that combines AI, medical device automation, and easier access to clinical expertise to support continuity of care in the home (the "Share Acquisition"). This strategic acquisition aligns with the Company's commitment to enhancing its portfolio in the healthcare tech
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- PRPheton Holdings Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyBeijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ:PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced, on October 20, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that based on the closing bid price of the Class A ordinary shares of the Company for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Th
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- PRPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading RumorsBEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company," "we," "our" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today issued the following statements in response to recent market volatility and a third-party publication that has raised questions and concerns among shareholders. Over the past few days, shares of Pheton have experienced an extraordinary and unexpected decline in its share price, which the Company believes may have been triggered by a speculative article published by The Bear Cave on July 29, 2025. The article asserts that Pheton's share price
- SECSEC Form SCHEDULE 13G filed by Pheton Holdings LtdSCHEDULE 13G - Pheton Holdings Ltd (0001970544) (Subject)
- SECSEC Form S-8 filed by Pheton Holdings LtdS-8 - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 20-F filed by Pheton Holdings Ltd20-F - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- SECSEC Form 6-K filed by Pheton Holdings Ltd6-K - Pheton Holdings Ltd (0001970544) (Filer)
- PRPheton Holdings Ltd Announces Closing of Initial Public OfferingBEIJING, China, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the closing of its initial public offering (the "Offering") of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses. The Company has granted the underwriters an option, exercisable within 45 days from the closing date of the Offering, to purchase up to an additional 337,500 Class A ordinary shares at the initi
- SECSEC Form 424B4 filed by Pheton Holdings Ltd424B4 - Pheton Holdings Ltd (0001970544) (Filer)
PTHL FAQ
6 questionsWhat is the latest news on PTHL?
Quantisnow has not tracked any new filings, ratings or press releases for PTHL in the last 30 days. The most recent wire item was published on January 13, 2026.Where does PTHL stock trade?
Pheton Holdings Ltd (PTHL) is listed on NASDAQ.What sector and industry is PTHL in?
Pheton Holdings Ltd operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Pheton Holdings Ltd go public?
Pheton Holdings Ltd (PTHL) completed its IPO in 2024.What companies are similar to PTHL?
Notable peers in the same industry include MDT (Medtronic plc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation), TMDX (TransMedics Group Inc.), AXGN (Axogen Inc.). Compare PTHL side-by-side with any of them on Quantisnow.How can I track PTHL on Quantisnow?
Quantisnow aggregates Pheton Holdings Ltd's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PTHL to receive live email and push alerts on every new disclosure.